T 0528/21 (Iduronate-2-sulfatase purification/TAKEDA) of 22.11.2023
- European Case Law Identifier
- ECLI:EP:BA:2023:T052821.20231122
- Date of decision
- 22 November 2023
- Case number
- T 0528/21
- Petition for review of
- -
- Application number
- 13809853.8
- IPC class
- A61K 38/17C07K 16/00C07K 1/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Purification of Iduronate-2-sulfatase
- Applicant name
- Takeda Pharmaceutical Company Limited
- Opponent name
- HGF Limited
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54(2)European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 011Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)Rules of procedure of the Boards of Appeal 2020 Art 013(1)
- Keywords
- New evidence filed with statement of grounds of appeal - circumstances of appeal case justify admittance (yes)
Late filed evidence - should have been submitted with statement of grounds of appeal
Remittal - (no)
Public availability of Kroean patent document upon registration - (yes)
Inventive step - (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.